Reproducibility and Repeatability of Quantitative T2 and T2* Mapping of Osteosarcomas in a Mouse Model

Overview

Journal Eur Radiol Exp

Date 2024 Jun 13

PMID 38872042

Authors

Raheleh Roudi

Laura J Pisani

Fabrizio Pisani

Tie Liang

Heike E Daldrup-Link

Affiliations

Soon will be listed here.

Abstract

Background: New immunotherapies activate tumor-associated macrophages (TAMs) in the osteosarcoma microenvironment. Iron oxide nanoparticles (IONPs) are phagocytosed by TAMs and, therefore, enable TAM detection on T2*- and T2-weighted magnetic resonance images. We assessed the repeatability and reproducibility of T2*- and T2-mapping of osteosarcomas in a mouse model.

Methods: Fifteen BALB/c mice bearing-murine osteosarcomas underwent magnetic resonance imaging (MRI) on 3-T and 7-T scanners before and after intravenous IONP infusion, using T2*-weighted multi-gradient-echo, T2-weighted fast spin-echo, and T2-weighted multi-echo sequences. Each sequence was repeated twice. Tumor T2 and T2* relaxation times were measured twice by two independent investigators. Repeatability and reproducibility of measurements were assessed.

Results: We found excellent agreement between duplicate acquisitions for both T2* and T2 measurements at either magnetic field strength, by the same individual (repeatability), and between individuals (reproducibility). The repeatability concordance correlation coefficient (CCC) for T2* values were 0.99 (coefficients of variation (CoV) 4.43%) for reader 1 and 0.98 (CoV 5.82%) for reader 2. The reproducibility of T2* values between the two readers was 0.99 (CoV 3.32%) for the first acquisitions and 0.99 (CoV 6.30%) for the second acquisitions. Regarding T2 values, the repeatability of CCC was similar for both readers, 0.98 (CoV 3.64% for reader 1 and 4.45% for reader 2). The CCC of the reproducibility of T2 was 0.99 (CoV 3.1%) for the first acquisition and 0.98 (CoV 4.38%) for the second acquisition.

Conclusions: Our results demonstrated high repeatability and reproducibility of quantitative T2* and T2 mapping for monitoring the presence of TAMs in osteosarcomas.

Relevance Statement: T2* and T2 measurements of osteosarcomas on IONP-enhanced MRI could allow identifying patients who may benefit from TAM-modulating immunotherapies and for monitoring treatment response. The technique described here could be also applied across a wide range of other solid tumors.

Key Points: • Optimal integration of TAM-modulating immunotherapies with conventional chemotherapy remains poorly elucidated. • We found high repeatability of T2* and T2 measurements of osteosarcomas in a mouse model, both with and without IONPs contrast, at 3-T and 7-T MRI field strengths. • T2 and T2* mapping may be used to determine response to macrophage-modulating cancer immunotherapies.

References

Li S, Liu J, Zhang F, Yang M, Zhang Z, Liu J . Novel T2 Mapping for Evaluating Cervical Cancer Features by Providing Quantitative T2 Maps and Synthetic Morphologic Images: A Preliminary Study. J Magn Reson Imaging. 2020; 52(6):1859-1869. DOI: 10.1002/jmri.27297. View

Tong S, Zhu H, Bao G . Magnetic Iron Oxide Nanoparticles for Disease Detection and Therapy. Mater Today (Kidlington). 2020; 31:86-99. PMC: 7441585. DOI: 10.1016/j.mattod.2019.06.003. View

Mohanty S, Yerneni K, Theruvath J, Graef C, Nejadnik H, Lenkov O . Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death Dis. 2019; 10(2):36. PMC: 6367456. DOI: 10.1038/s41419-018-1285-3. View

Strauss S, Frezza A, Abecassis N, Bajpai J, Bauer S, Biagini R . Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021; 32(12):1520-1536. DOI: 10.1016/j.annonc.2021.08.1995. View

Koo T, Li M . A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016; 15(2):155-63. PMC: 4913118. DOI: 10.1016/j.jcm.2016.02.012. View

Cancado R, Watman N, Lobo C, Chona Z, Manzur F, Traina F . Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study. Hematology. 2018; 23(9):676-682. DOI: 10.1080/10245332.2018.1461292. View

Cheng K, Duan Q, Hu J, Li C, Ma X, Bian X . Evaluation of postcontrast images of intracranial tumors at 7T and 3T MRI: An intra-individual comparison study. CNS Neurosci Ther. 2022; 29(2):559-565. PMC: 9873521. DOI: 10.1111/cns.14036. View

Westwood M, Firmin D, Gildo M, Renzo G, Stathis G, Markissia K . Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging. 2005; 21(5):531-8. DOI: 10.1007/s10554-005-0651-2. View

Violi N, Hilbert T, Bastiaansen J, Knebel J, Ledoux J, Stemmer A . Patient respiratory-triggered quantitative T mapping in the pancreas. J Magn Reson Imaging. 2019; 50(2):410-416. PMC: 6766866. DOI: 10.1002/jmri.26612. View

10.

Aghighi M, Theruvath A, Pareek A, Pisani L, Alford R, Muehe A . Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation. Clin Cancer Res. 2018; 24(17):4110-4118. PMC: 6125171. DOI: 10.1158/1078-0432.CCR-18-0673. View

11.

Raudner M, Schreiner M, Hilbert T, Kober T, Weber M, Windhager R . Accelerated T2 Mapping of the Lumbar Intervertebral Disc: Highly Undersampled K-Space Data for Robust T2 Relaxation Time Measurement in Clinically Feasible Acquisition Times. Invest Radiol. 2020; 55(11):695-701. PMC: 7116776. DOI: 10.1097/RLI.0000000000000690. View

12.

Mohanty S, Aghighi M, Yerneni K, Theruvath J, Daldrup-Link H . Improving the efficacy of osteosarcoma therapy: combining drugs that turn cancer cell 'don't eat me' signals off and 'eat me' signals on. Mol Oncol. 2019; 13(10):2049-2061. PMC: 6763764. DOI: 10.1002/1878-0261.12556. View

13.

Lin L . A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989; 45(1):255-68. View

14.

ter Voert E, Heijmen L, de Wilt J, Bussink J, Punt C, van Laarhoven H . Reproducibility and biological basis of in vivo T(2)* magnetic resonance imaging of liver metastasis of colorectal cancer. Magn Reson Med. 2012; 70(4):1145-52. DOI: 10.1002/mrm.24543. View

15.

Positano V, Salani B, Pepe A, Santarelli M, De Marchi D, Ramazzotti A . Improved T2* assessment in liver iron overload by magnetic resonance imaging. Magn Reson Imaging. 2008; 27(2):188-97. DOI: 10.1016/j.mri.2008.06.004. View

16.

Ge Y, Hu S, Wang Z, Guan R, Zhou X, Gao Q . Feasibility and reproducibility of T2 mapping and DWI for identifying malignant lymph nodes in rectal cancer. Eur Radiol. 2020; 31(5):3347-3354. DOI: 10.1007/s00330-020-07359-7. View

17.

Bartlett J, Frost C . Reliability, repeatability and reproducibility: analysis of measurement errors in continuous variables. Ultrasound Obstet Gynecol. 2008; 31(4):466-75. DOI: 10.1002/uog.5256. View

18.

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

19.

Alonzi R, Taylor N, Stirling J, dArcy J, Collins D, Saunders M . Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate. J Magn Reson Imaging. 2010; 32(1):155-64. DOI: 10.1002/jmri.22215. View

20.

Meloni A, Luciani A, Positano V, De Marchi D, Valeri G, Restaino G . Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload. J Magn Reson Imaging. 2011; 33(2):348-55. DOI: 10.1002/jmri.22417. View